ALISON MULLARKEY: Open Payments
NPI 1497088926 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 22 payments from 6 companies in 2025. Trend: 2023 $21 · 2024 $212 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $175 |
| Novo Nordisk Inc | 5 | $118 |
| Exact Sciences Corporation | 3 | $74 |
| Lilly USA, LLC | 3 | $64 |
| Gilead Sciences, Inc. | 2 | $56 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Wegovy, PREVNAR 20, MOUNJARO, The Cologuard Plus Collection Kit, ELIQUIS, NURTEC ODT, Cologuard Collection Kit, PAXLOVID.
Industry payments across DC — which companies pay providers there.
